Research & Development



  到了盛世,他們就會認為肉食者鄙,躲在深山老林里與松鶴清風明月相伴,彰顯自己高人一等的聖人風範。毛片基地   老宦官搖頭道︰“沒可能,金冠已經出現,大月氏公主梅里亞也出現了,就說明冒頓的陵墓就在這里,只是墓葬區太大了,想要在短時間找到棺槨就要看運氣了。說實話,某家的運氣一向算不得好。”色姐妹综合网   謝長川笑道︰“你就沒看出這些猴崽子真正的意圖是什麼?”   雲瑯只好拿起毯子給老不死的蓋上,還特地把毯子腳塞好,免得透風。亚州性夜夜射   “別跑了,考驗一個人能否有堅持,就在這個時候,這個時候如果挺住了,往後,你的前路將會一帆風順,這時候要是跑路了,你以前做的全部都白費了。我要是有你這一身勇力,就會去白登山跟匈奴人死戰,同樣的道理,現在殺一個匈奴人,等于以前殺十個匈奴人。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo